Phase I Study of Yttrium-90 Radiolabeled M5A Anti-Carcinoembryonic Antigen Humanized Antibody in Patients with Advanced Carcinoembryonic Antigen Producing Malignancies

Lignende værker

• A Pretherapy Biodistribution and Dosimetry Study of Indium-111-Radiolabeled Trastuzumab in Patients with Human Epidermal Growth Factor Receptor 2-Overexpressing Breast Cancer
  af: Wong, Jeffrey Y.C., et al.
  Udgivet: (2010)
• The development, commercialization, and clinical context of yttrium-90 radiolabeled resin and glass microspheres
  af: Westcott, Mark A., et al.
  Udgivet: (2016)
• The development, commercialization, and clinical context of yttrium-90 radiolabeled resin and glass microspheres
  af: Mark A. Westcott, MD, et al.
  Udgivet: (2016-10-01)
• A VERSATILE BIFUNCTIONAL CHELATE FOR RADIOLABELING HUMANIZED ANTI-CEA ANTIBODY WITH IN-111 AND CU-64 AT EITHER THIOL OR AMINO GROUPS: PET IMAGING OF CEA-POSITIVE TUMORS WITH WHOLE ANTIBODIES
  af: Li, Lin, et al.
  Udgivet: (2007)
• Phase I/II Trial of Anticarcinoembryonic Antigen Radioimmunotherapy, Gemcitabine, and Hepatic Arterial Infusion of Fluorodeoxyuridine Postresection of Liver Metastasis for Colorectal Carcinoma
  af: Cahan, Benjamin, et al.
  Udgivet: (2017)